AQR Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.85M Sell
50,267
-16,950
-25% -$3.29M ﹤0.01% 1351
2025
Q4
$11.7M Buy
67,217
+17,149
+34% +$3.12M 0.01% 1145
2025
Q3
$9.51M Buy
50,068
+651
+1% +$116K 0.01% 1117
2025
Q2
$8.8M Sell
49,417
-5,235
-10% -$909K 0.01% 1017
2025
Q1
$9.25M Sell
54,652
-91,935
-63% -$15.1M 0.01% 901
2024
Q4
$22.1M Sell
146,587
-116,750
-44% -$18.2M 0.03% 604
2024
Q3
$40.6M Buy
263,337
+115,868
+79% +$17.3M 0.06% 432
2024
Q2
$20.2M Buy
147,469
+23,150
+19% +$3.17M 0.03% 580
2024
Q1
$16.5M Buy
124,319
+21,483
+21% +$2.79M 0.03% 581
2023
Q4
$14.1M Sell
102,836
-46,725
-31% -$6.14M 0.03% 590
2023
Q3
$18.2M Sell
149,561
-67,446
-31% -$8.99M 0.04% 498
2023
Q2
$30.5M Sell
217,007
-141,686
-40% -$19.5M 0.06% 350
2023
Q1
$50.3M Sell
358,693
-179,293
-33% -$25.7M 0.11% 222
2022
Q4
$83.9M Sell
537,986
-154,127
-22% -$22.1M 0.19% 126
2022
Q3
$84.9M Sell
692,113
-115,027
-14% -$15.1M 0.21% 109
2022
Q2
$107M Buy
807,140
+29,422
+4% +$4.01M 0.24% 91
2022
Q1
$106M Sell
777,718
-1,282
-0.2% -$179K 0.2% 111
2021
Q4
$134M Sell
779,000
-43,434
-5% -$6.61M 0.24% 95
2021
Q3
$120M Buy
822,434
+451,088
+121% +$66M 0.22% 110
2021
Q2
$49M Sell
371,346
-141,355
-28% -$18.5M 0.08% 267
2021
Q1
$65.4M Sell
512,701
-70,714
-12% -$8.71M 0.11% 222
2020
Q4
$68.6M Buy
583,415
+267,722
+85% +$32.6M 0.12% 195
2020
Q3
$36.1M Sell
315,693
-8,993
-3% -$1.06M 0.06% 341
2020
Q2
$35.9M Sell
324,686
-172,888
-35% -$18.3M 0.06% 346
2020
Q1
$40M Buy
497,574
+199,470
+67% +$20.7M 0.07% 326
2019
Q4
$31.7M Buy
298,104
+107,921
+57% +$11.3M 0.04% 486
2019
Q3
$20.4M Sell
190,183
-98,054
-34% -$10.1M 0.02% 591
2019
Q2
$29.2M Sell
288,237
-49,304
-15% -$4.74M 0.03% 499
2019
Q1
$30.4M Buy
337,541
+18,601
+6% +$1.61M 0.03% 512
2018
Q4
$26.6M Buy
318,940
+192,743
+153% +$18.1M 0.03% 500
2018
Q3
$13.6M Sell
126,197
-2,849
-2% -$312K 0.01% 689
2018
Q2
$14.2M Sell
129,046
-97,696
-43% -$10.2M 0.01% 676
2018
Q1
$22.7M Buy
226,742
+9,430
+4% +$966K 0.02% 559
2017
Q4
$21.4M Sell
217,312
-64,467
-23% -$6.11M 0.02% 591
2017
Q3
$26.4M Sell
281,779
-475,160
-63% -$50.4M 0.03% 523
2017
Q2
$84.1M Sell
756,939
-360,599
-32% -$38.1M 0.11% 243
2017
Q1
$110M Sell
1,117,538
-150,421
-12% -$14.3M 0.15% 195
2016
Q4
$117M Sell
1,267,959
-6,661
-0.5% -$574K 0.16% 169
2016
Q3
$108M Sell
1,274,620
-276,926
-18% -$23.3M 0.17% 170
2016
Q2
$126M Sell
1,551,546
-84,874
-5% -$6.46M 0.22% 120
2016
Q1
$117M Buy
1,636,420
+72,892
+5% +$4.89M 0.21% 138
2015
Q4
$111M Buy
1,563,528
+1,187,980
+316% +$79.9M 0.19% 137
2015
Q3
$23.1M Buy
375,548
+245,623
+189% +$17.2M 0.05% 445
2015
Q2
$9.42M Buy
129,925
+102,578
+375% +$7.57M 0.02% 633
2015
Q1
$2.1M Buy
+27,347
New +$1.96M ﹤0.01% 1082
2014
Q3
Sell
-13,589
Closed -$798K 2530
2014
Q2
$798K Buy
13,589
+1,000
+8% +$58.6K ﹤0.01% 1757
2014
Q1
$729K Sell
12,589
-76,100
-86% -$4.08M ﹤0.01% 1859
2013
Q4
$4.75M Buy
88,689
+47,065
+113% +$2.79M 0.01% 905
2013
Q3
$2.57M Sell
41,624
-33,865
-45% -$2.03M 0.01% 1134
2013
Q2
$4.58M Buy
+75,489
New +$4.5M 0.02% 902

Other funds holding DGX

AQR Capital Management's DGX Position: Q1 2026 in Review

AQR Capital Management reduced its Quest Diagnostics (DGX) stake by 25% in Q1 2026, selling an estimated $3.29M and leaving 50,267 shares worth $9.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

AQR Capital Management first reported a position in DGX in Q2 2013 and has held it in 50 quarters since. The position peaked at $134M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • AQR Capital Management held 50,267 shares of Quest Diagnostics worth $9.85M as of Q1 2026.
  • AQR Capital Management sold 16,950 Quest Diagnostics shares in Q1 2026, an estimated $3.29M.
  • Quest Diagnostics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1351 holding.
  • AQR Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 50 quarters since.
  • AQR Capital Management's Quest Diagnostics position peaked at $134M in Q4 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.